Last edition
News about Global Pharma
Granules India Limited Received ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets
It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Protonix Delayed-Release Tablets, 20 mg and 40 mg, of Wyeth Pharmaceuticals LLC.
Global Pharma | 14/12/2023 | By Manvi | 857
Zydus Lifesciences and Daewoong Pharmaceutical Co., Ltd. announced that they have entered into an exclusive licensing agreement to co-develop and commercialize Leuprolide Acetate for Depot Suspension in six dosage strengths for the United States (US) market.
Global Pharma | 13/12/2023 | By Manvi | 674
ANTABIO Raises Euro 25 Million in Series B Financing
Antabio SAS announced that it has raised Euro 25 million in a series B financing round with subscriptions from the AMR Action Fund.
Global Pharma | 13/12/2023 | By Manvi | 682
Sterling Accuris Expands into Pharmaceutical and Analytical Testing
With this acquisition, Sterling Accuris has successfully expanded its range of services offered to fields such as pharmaceutical analytical testing.
Global Pharma | 13/12/2023 | By Manvi | 439
DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC
DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC - a Sterile Dosage Manufacturing Facility in North Carolina, US, Strengthening Its Position in Developing and Manufacturing Complex Differentiated Sterile Dosage Formulations
Global Pharma | 13/12/2023 | By Manvi | 1314
ACG Inspection Launch Cloud-Based Offering Addressing VRS Requirements Under DSCSA Regulations
The new system, which forms part of the ACG’s Inspections Life Sciences Cloud Service and Compliance Gateway, enables the automatic verification of saleable returns through product identifiers by routing requests and responses between stakeholders.
Global Pharma | 13/12/2023 | By Manvi | 527
Ferring and Pharmabiome Enter A Microbiome R&D Collaboration and Licensing Agreement
Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology.
Global Pharma | 13/12/2023 | By Manvi | 498
Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide.
Global Pharma | 13/12/2023 | By Manvi | 321
PharmaKure and UiTM Collaborate for Advance Research in Alzheimer's Disease Diagnosis
The partnership is focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships.
Global Pharma | 12/12/2023 | By Manvi | 583
Chinese Company to Set Up Pharmaceutical Ingredients Factory in BEPZA EZ
Chinese company Crescent Hi Tech Co. Ltd. is going to set up an ‘Active Pharmaceutical Ingredients (API)’ manufacturing industry in BEPZA Economic Zone.
Global Pharma | 12/12/2023 | By Manvi | 298
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy